{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "firstTradeDateMilliseconds": 1595251800000, "priceHint": 4, "exchange": "PNK", "shortName": "SYNAIRGEN", "longName": "Synairgen plc", "messageBoardId": "finmb_20361040", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.11695, "marketState": "PRE", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.0, "regularMarketTime": 1683301906, "regularMarketDayHigh": 0.11695, "regularMarketDayRange": "0.11695 - 0.11695", "regularMarketDayLow": 0.11695, "regularMarketVolume": 500, "regularMarketPreviousClose": 0.11695, "fullExchangeName": "Other OTC", "financialCurrency": "GBP", "regularMarketOpen": 0.11695, "averageDailyVolume3Month": 801, "averageDailyVolume10Day": 180, "fiftyTwoWeekLowChange": 0.045949996, "fiftyTwoWeekLowChangePercent": 0.647183, "fiftyTwoWeekRange": "0.071 - 0.486", "fiftyTwoWeekHighChange": -0.36905, "fiftyTwoWeekHighChangePercent": -0.7593621, "fiftyTwoWeekLow": 0.071, "fiftyTwoWeekHigh": 0.486, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.11, "sharesOutstanding": 201375008, "bookValue": 0.101, "fiftyDayAverage": 0.12076, "fiftyDayAverageChange": -0.0038100034, "fiftyDayAverageChangePercent": -0.03155021, "twoHundredDayAverage": 0.193185, "twoHundredDayAverageChange": -0.076235004, "twoHundredDayAverageChangePercent": -0.39462176, "marketCap": 23550806, "priceToBook": 1.1579207, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "displayName": "Synairgen", "symbol": "SYGGF"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Mailpoint 810", "address2": "Level F, South Block Southampton General Hospital Tremona Road", "city": "Southampton", "zip": "SO16 6YD", "country": "United Kingdom", "phone": "44 23 8051 2800", "fax": "44 23 8051 2800", "website": "https://www.synairgen.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-\u00df), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-\u00df that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard  Marsden", "age": 54, "title": "CEO, MD & Exec. Director", "yearBorn": 1968, "fiscalYear": 2021, "totalPay": {"raw": 1272390, "fmt": "1.27M", "longFmt": "1,272,390"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 2270219, "fmt": "2.27M", "longFmt": "2,270,219"}}, {"maxAge": 1, "name": "Prof. Stephen T. Holgate CBE, M.D.", "age": 74, "title": "Co-Founder, Non-Exec. Director & Member of Scientific Advisory Board", "yearBorn": 1948, "fiscalYear": 2021, "totalPay": {"raw": 37350, "fmt": "37.35k", "longFmt": "37,350"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John  Ward", "age": 60, "title": "CFO & Exec. Director", "yearBorn": 1962, "fiscalYear": 2021, "totalPay": {"raw": 1104315, "fmt": "1.1M", "longFmt": "1,104,315"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1765726, "fmt": "1.77M", "longFmt": "1,765,726"}}, {"maxAge": 1, "name": "Dr. Phillip David Monk", "age": 53, "title": "Chairman of Scientific Advisory Board, Chief Scientific Officer & Exec. Director", "yearBorn": 1969, "fiscalYear": 2021, "totalPay": {"raw": 943710, "fmt": "943.71k", "longFmt": "943,710"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1639604, "fmt": "1.64M", "longFmt": "1,639,604"}}, {"maxAge": 1, "name": "Prof. Donna  Davies", "title": "Co-Founder & Member of Scientific Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Ratko  Djukanovic", "title": "Co-Founder & Member of Scientific Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Brooke S Clarke", "title": "Sr. VP & Head of Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Gareth E. Walters Ph.D.", "age": 63, "title": "Chief Regulatory Officer", "yearBorn": 1959, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jody  Brookes", "title": "Sr. VP & Head of Clinical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Richard  Hennings", "age": 52, "title": "Chief Commercial Officer", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}